PHAR vs NBTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

PHAR

39.1
AI Score
VS
NBTX Wins

NBTX

38.5
AI Score

Investment Advisor Scores

PHAR

39score
Recommendation
AVOID NEW MONEY

NBTX

39score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric PHAR NBTX Winner
Forward P/E 212.766 42.3729 NBTX
PEG Ratio 0 0 Tie
Revenue Growth -3.2% 186.8% NBTX
Earnings Growth -62.9% 0.0% NBTX
Tradestie Score 39.1/100 38.5/100 PHAR
Profit Margin 2.5% -73.5% PHAR
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

PHAR 1M: -12.9% · 3M: -31.9% NBTX 1M: -38.2% · 3M: -37.3%

Current Technical Phase

PHAR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.5%), weak momentum, RSI 34

RSI (14): 33.8 · Price: $9.75

NBTX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.4%), weak momentum, RSI 25

RSI (14): 25.2 · Price: $25.75

Fundamentals Snapshot

Metric PHAR NBTX
Market Cap — —
Forward P/E 31.8 -172.5
Trailing P/E 71.1 —
Revenue (TTM) — —
Revenue Growth 0.0% 1.9%
Gross Margin 0.9% 1.0%
Operating Margin 0.0% -2.0%
EPS 0.14 -1.10
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NBTX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.